Literature DB >> 33411736

A novel type of colistin resistance genes selected from random sequence space.

Michael Knopp1,2, Arianne M Babina1, Jónína S Gudmundsdóttir1, Martin V Douglass3, M Stephen Trent3,4, Dan I Andersson1.   

Abstract

Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura.

Entities:  

Year:  2021        PMID: 33411736      PMCID: PMC7790251          DOI: 10.1371/journal.pgen.1009227

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   5.917


  60 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 2.  Evolution of extended-spectrum beta-lactamases by mutation.

Authors:  M Gniadkowski
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

3.  A hidden Markov model for predicting transmembrane helices in protein sequences.

Authors:  E L Sonnhammer; G von Heijne; A Krogh
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1998

4.  No beneficial fitness effects of random peptides.

Authors:  Michael Knopp; Dan I Andersson
Journal:  Nat Ecol Evol       Date:  2018-07       Impact factor: 15.460

Review 5.  Pervasive transcription: illuminating the dark matter of bacterial transcriptomes.

Authors:  Joseph T Wade; David C Grainger
Journal:  Nat Rev Microbiol       Date:  2014-07-28       Impact factor: 60.633

Review 6.  The rise and spread of mcr plasmid-mediated polymyxin resistance.

Authors:  Sue C Nang; Jian Li; Tony Velkov
Journal:  Crit Rev Microbiol       Date:  2019-05-23       Impact factor: 7.624

7.  Prebiotic synthesis of hydrophobic and protein amino acids.

Authors:  D Ring; Y Wolman; N Friedmann; S L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

8.  Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A.

Authors:  An X Tran; Mark J Karbarz; Xiaoyuan Wang; Christian R H Raetz; Sara C McGrath; Robert J Cotter; M Stephen Trent
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

9.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Authors:  Evelina Tacconelli; Elena Carrara; Alessia Savoldi; Stephan Harbarth; Marc Mendelson; Dominique L Monnet; Céline Pulcini; Gunnar Kahlmeter; Jan Kluytmans; Yehuda Carmeli; Marc Ouellette; Kevin Outterson; Jean Patel; Marco Cavaleri; Edward M Cox; Chris R Houchens; M Lindsay Grayson; Paul Hansen; Nalini Singh; Ursula Theuretzbacher; Nicola Magrini
Journal:  Lancet Infect Dis       Date:  2017-12-21       Impact factor: 71.421

10.  De Novo Emergence of Peptides That Confer Antibiotic Resistance.

Authors:  Michael Knopp; Jonina S Gudmundsdottir; Tobias Nilsson; Finja König; Omar Warsi; Fredrika Rajer; Pia Ädelroth; Dan I Andersson
Journal:  mBio       Date:  2019-06-04       Impact factor: 7.867

View more
  6 in total

Review 1.  Bacterial Small Membrane Proteins: the Swiss Army Knife of Regulators at the Lipid Bilayer.

Authors:  Srujana S Yadavalli; Jing Yuan
Journal:  J Bacteriol       Date:  2021-09-13       Impact factor: 3.476

Review 2.  The Origins and Functions of De Novo Genes: Against All Odds?

Authors:  Caroline M Weisman
Journal:  J Mol Evol       Date:  2022-04-22       Impact factor: 3.973

3.  Identification of colistin resistance and its bactericidal activity against uropathogenic gram negative bacteria from Hayatabad Medical Complex Peshawar.

Authors:  Ambreen Arif; Ihsan Ullah; Obaid Ullah; Ronaq Zaman
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

4.  Small Proteins; Big Questions.

Authors:  Todd Gray; Gisela Storz; Kai Papenfort
Journal:  J Bacteriol       Date:  2021-07-26       Impact factor: 3.476

5.  Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.

Authors:  Jennifer Jagdmann; Dan I Andersson; Hervé Nicoloff
Journal:  PLoS Biol       Date:  2022-09-28       Impact factor: 9.593

6.  The Effects of Sequence Length and Composition of Random Sequence Peptides on the Growth of E. coli Cells.

Authors:  Johana F Castro; Diethard Tautz
Journal:  Genes (Basel)       Date:  2021-11-28       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.